personalized medicine

Research in Review

HER2 Inhibitors Demonstrate Variable Effects in Solid Cancers

07/25/2017

JCP Editors

Human epidermal growth factor receptor 2 (HER2)-targeted therapy results in different objective response rates (ORR) across cancer types based on mutation variants, according to recent research. ----- Related...

Human...

07/25/2017

Journal of Clinical Pathways

Research in Review

Prostate Cancer Subtypes Respond Differently to Androgen Deprivation Therapy

05/17/2017

JCP Editors

Luminal and basal subtyping of prostate cancer may provide a clinical tool for predicting which patients will benefit from androgen deprivation therapy (ADT) after prostatectomy, according to a report published in...

...

05/17/2017

Journal of Clinical Pathways

Research in Review

CAR T-Cells Offer Biomarker for Objective Response in Non-Hodgkin Lymphoma

04/28/2017

JCP Editors

The ability of chimeric antigen receptor (CAR) T-cells to perform multiple functions is associated with improved outcomes for patients with advanced non-Hodgkin lymphoma, offering a biomarker for response, according...

The...

04/28/2017

Journal of Clinical Pathways

Editor's Page

A Greater Focus on the Patient

09/06/2016

Winston Wong, PharmD, Editor-in-Chief

One of the core goals of clinical pathways development has always been to make health care more patient-centered. However, a common complaint regarding clinical pathway development is that patients are often left out...

One of...

09/06/2016

Journal of Clinical Pathways

Research in Review

Barriers Predict Nonadherence to Treatment for Early-Stage Breast Cancer

09/06/2016

JCP Editors

Perceived barriers to treatment may predict patient nonadherence to aromatase inhibitors for women with early-stage, estrogen receptor-positive breast cancer, claims a study published in Cancer. While patient...

...

09/06/2016

Journal of Clinical Pathways

Research in Review

Tool Helps Reduce Patient Stress Surrounding Prostate Cancer Care

07/22/2016

JCP Editors

A new tool may help make decisions less emotional for patients with low-risk prostate cancer and encourage patient-physician communication, according to results published in the Journal of Cancer Education. While...

A new...

07/22/2016

Journal of Clinical Pathways

Research in Review

Genetic Test Shows Which Breast Cancer Patients Can Bypass Chemotherapy

09/29/2015

JCP Editors

Analysis of gene expression in post-surgery breast cancer has helped researchers identify which patients can bypass chemotherapy after surgery. A longer follow-up study will be needed to verify the results, but...

...

09/29/2015

Journal of Clinical Pathways